期刊文献+

糖尿病性黄斑水肿与糖尿病视网膜病变的相关性及危险因素的分析 被引量:4

Analysis of the Correlation and Risk Factors between Diabetic Macular Edema and Diabetic Retinopathy
下载PDF
导出
摘要 为探讨糖尿病性黄斑水肿与多发因素(病程、高血糖及胰岛素应用、蛋白尿、体重)的关系,对糖尿病患者的病史、病程,体重、收缩压、舒张压、尿微量白蛋白及相关生化指标进行了研究,发现糖尿病患者的病程、高血糖、高血压、高血脂、蛋白尿、体重等全身因素和局部因素均对糖尿病性黄斑水肿(DME)的发生有着促进的作用. To investigate the relationship between diabetic macular edema(DME)and multiple factors such as diabe-tes duration, hyperglycemia, insulin application, albuminuria and weight, we studied the medical history, diabetes dura-tion, weight, systolic pressure, diastolic pressure, microalbuminuria and related biochemical indexes of all patients. Re-search showed that systemic factors such as diabetes duration, high blood glucose, hypertension, hyperlipidemia, albu-minuria, weight and some local factors contributed to DME.
作者 常宏 张天资
出处 《内蒙古民族大学学报(自然科学版)》 2014年第2期223-225,共3页 Journal of Inner Mongolia Minzu University:Natural Sciences
关键词 糖尿病性黄斑水肿 定义 危险因素 Diabetic macular edema Definition Risk factor
  • 相关文献

参考文献19

  • 1Klein R, Klein BE ,Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X V.The long-term incidence of macular edema[J].Ophthalmology ,1995,102:7216.
  • 2Ciulla TA.Amador AG,ZimanB.Diabietic retinopathy and diabietic macular edema pathophysiology screening and novel therapies[J].Diabotes Care,2003,26:2653-2664.
  • 3Klein R, Mooss SE,Klein BE ,et al.The Wisconsin epidemiologic study of diabetic retinopathy[J]. The incidence of macular edema Ophthalmology, 1989,96: 1501-1510.
  • 4Eva M.Kohner, StephenJ.A Idington, et al. United Kingdom Prospective Diabetes Study 30 Diabetic Retinopathy at Diagnoses of Non- Insulin- dependent Diabetes Mellitus and Associated Risk Factors[J]. Arch Ophthalmol, 1998, 116:305- 312.
  • 5Harris AG, Skalak TC, Hatchell DL. Leukocyte-capillary plugging and network Resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia[J]. IntJ Microcirc Clin Exp, 1994,14(3) : 159-166.
  • 6C. -H. Lai, T. -H. Choul, P.-C. Wu, et al. Relationship of Diabetic Macular Edema With Glycosylated Hemoglobin (HbAlc) [J].Invest Ophthalmol Vis Sci,2008.49.
  • 7H .Kim.I. Yang, Y .Kim , et al.Risk Factors for Diffuse Macular Edema Classified by Optical Coherence Tomography [J] .Invest Ophthalmol Vis sa.zooa 49.
  • 8Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and ComplicationsTrial[J].Ophthalmology,1995,102: 647-661.
  • 9Aroea PR,Salvat M,FemandezJ ,et al.Risk factors for difuse and foeal maeular edemalJj.J Diabetes Com Plieations,2004, 18: 211-215.
  • 10Aroca PR,Salvat M, FernandezJ, Mendez LRisk factors for difluse and focal macular edemalJ},J Diabeteg Complications, 2004,18 :211-215.

二级参考文献30

  • 1Early Treatment Diabetic Retinopathy Study Research Group.Photocoagulation for diabetic macular edema.ETDRS report number 1.Arch Ophthalmol,1985,103:1796-1806.
  • 2Kent D,Vinores SA,Campochiaro PA.Macular oedema:the role of soluble mediators.Br J Ophthalmol,2000,84:542-545.
  • 3Eva M.Kohner,Stephen J.A Idington,Irene M.Stratton,et al.United Kingdom Prospective Diabetes Study 30 Diabetic Retinopathy at Diagnoses of Non-Insulin-dependent Diabetes Mellitus and Associated Risk Factors.Arch Ophthalmol,1998,116:305-312.
  • 4UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ, 1998,317:703-713.
  • 5Heart Outcomes Prevention Evaluation Study Investigators. Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes. Lancet, 2000, 355:253-259.
  • 6Brenner BM, Cooper ME, Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001,345:861-869.
  • 7Julius S, Majahalme S, Palatini P. Antihypertensive treatment of patients with diabetes and hypertension. Am J Hypertens, 2001,14:310S-316S.
  • 8Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. Lancet, 1998,351:1755-1762.
  • 9Curb JD, Pressel Sl, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA, 1996,276:1886-1892.
  • 10Tuomilehto J, Rastenyte D, Birkenhager WH, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med, 1999,340:677-684.

共引文献73

同被引文献33

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部